Ultrasis Interactive Healthcare fka LSE:ULT

[woolworth]

Ultrasis (ULT) August 2103 NHS/USA..

Another company that has disappointed for several years is Ultrasis. Shares in this interactive healthcare company have been in a downtrend since 2006. The main problem for Ultrasis has been that sales of their flagship ‘Beating the Blues’ product to the NHS have fallen away.

However, things are changing at Ultrasis and this is reflected in a clear chart breakout in the last few weeks. The Company has recently reported good progress with ‘Beating the Blues’ in the USA. Also, the replacement of CEO Nigel Brabbins with Marketing Director, John Smith has been well received by the market. John is in position as an Interim CEO while the board “look for a suitable replacement for Mr Brabbins.

The flow of good news continued on 1 August when Ultrasis announced that it had entered a new business partnership with Cheshire and Wirral Partnership NHS Foundation Trust. The RNS reported that "The two organisations will establish a jointly-owned company, in which they will hold equal shares, to deliver a range of computerised healthcare products and clinical interventions - including Ultrasis' leading "Beating the Blues" therapy programme for stress and depression."

John Smith, Chief Executive of Ultrasis, added: "This is a significant development for our business and marks the start of our strategic refocus to become "a provider of comprehensive healthcare solutions rather than just a developer of software. CWP has an exceptional reputation for quality service provision and excellent clinical governance arrangements, both of which are required to meet the needs of the new commissioning arrangements of the NHS."

AimZine Comment: Cracking the NHS and the USA are big challenges for Ultrasis but the Interim CEO has got off to a very good start in his first few weeks in post.

http://www.investorschampion.com/aimzine/entry/time-for-some-risks